The Long Run with Luke Timmerman

Timmerman Report
undefined
Jan 31, 2022 • 1h 11min

Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules

Praveen Tipirneni, CEO of Morphic Therapeutic, on targeting integrins with small molecules.
undefined
Jan 11, 2022 • 1h 4min

Ep107: Bassil Dahiyat on Antibody Engineering & Company Building

Bassil Dahiyat of Xencor on antibody engineering and company building.
undefined
Dec 20, 2021 • 1h 11min

Ep106: Vineeta Agarwala on Health Data & VC Investing

Vineeta Agarwala, general partner with Andreesen Horowitz's bio fund, on investing in therapeutics, diagnostics and digital health.
undefined
Dec 6, 2021 • 1h 8min

Ep105: Nello Mainolfi on Targeted Protein Degraders

Nello Mainolfi, CEO of Kymera Therapeutics, on targeted protein degrading small molecule drugs.
undefined
Dec 1, 2021 • 1h 7min

Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity

Jeff Bluestone, CEO of Sonoma Biotherapeutics, on engineered T-reg cell therapies for autoimmunity.
undefined
Nov 23, 2021 • 1h 1min

Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer

Ken Song, CEO of RayzeBio, on targeted radiopharmaceuticals for cancer.
undefined
Nov 8, 2021 • 1h 12min

Ep102: David Baltimore Reflects on a Life in Science

David Baltimore, professor emeritus at Caltech, reflects on a life in science.
undefined
Oct 26, 2021 • 1h 13min

Ep101: Tony Kulesa on Fostering Founder-Led Biotechs

Tony Kulesa of Petri.bio on fostering founder-led biotech companies
undefined
Oct 13, 2021 • 1h 10min

Ep100: Christian Henry on Long Read DNA Sequencing

Christian Henry, CEO of PacBio, on long read DNA sequencing applications.
undefined
Sep 27, 2021 • 1h 9min

Ep99: Keolu Fox on Genome Sequencing of Indigenous Populations

Keolu Fox, assistant professor at UC San Diego, on genome sequencing of indigenous populations.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app